Llwytho...
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results
BACKGROUND: Multiple sclerosis (MS) is a chronic disease that may require decades of ongoing treatment. Therefore, the long-term safety and efficacy of disease-modifying therapies is an important consideration. METHODS: The LONGTERMS study evaluated the safety and efficacy of fingolimod in patients...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Adv Neurol Disord |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763939/ https://ncbi.nlm.nih.gov/pubmed/31598139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419878324 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|